Masakazu Fujimoto, Yuki Teramoto, Kai Mizoguchi, Kodai Furuta, Hiroyuki Irie, Yo Kaku, Masahiro Hirata, Kenji Kabashima, Hironori Haga
{"title":"在Stevens-Johnson综合征和中毒性表皮坏死松解的表皮中,髓过氧化物酶阳性的单核细胞多于cd3阳性的t淋巴细胞。","authors":"Masakazu Fujimoto, Yuki Teramoto, Kai Mizoguchi, Kodai Furuta, Hiroyuki Irie, Yo Kaku, Masahiro Hirata, Kenji Kabashima, Hironori Haga","doi":"10.1007/s00428-025-04279-z","DOIUrl":null,"url":null,"abstract":"<p><p>Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening mucocutaneous conditions traditionally regarded as severe T cell-mediated hypersensitivity reactions. However, recent evidence has highlighted the potential role of myeloperoxidase (MPO), primarily produced by neutrophils, in the pathogenesis of SJS/TEN. Here, we examined the expression of MPO in skin biopsy specimens from patients with SJS/TEN (n = 15) to evaluate its diagnostic utility, comparing the findings with those from patients with erythema multiforme (EM) (n = 8) and graft-versus-host disease (GVHD) (n = 10). MPO-positive mononuclear cells were present in all SJS/TEN cases, often outnumbering CD3-positive T cells (86.7%). A significantly higher number of cases with an MPO/CD3 ratio greater than 1 was observed in patients with SJS/TEN compared with that in patients with GVHD (p < 0.01). However, no such difference was observed between SJS/TEN and EM. These findings suggest that an MPO/CD3 > 1 is a pathologic feature of SJS/TEN; however, its specificity may be limited.</p>","PeriodicalId":23514,"journal":{"name":"Virchows Archiv","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Myeloperoxidase-positive mononuclear cells predominate over CD3-positive T-lymphocytes in the epidermis of Stevens-Johnson syndrome and toxic epidermal necrolysis.\",\"authors\":\"Masakazu Fujimoto, Yuki Teramoto, Kai Mizoguchi, Kodai Furuta, Hiroyuki Irie, Yo Kaku, Masahiro Hirata, Kenji Kabashima, Hironori Haga\",\"doi\":\"10.1007/s00428-025-04279-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening mucocutaneous conditions traditionally regarded as severe T cell-mediated hypersensitivity reactions. However, recent evidence has highlighted the potential role of myeloperoxidase (MPO), primarily produced by neutrophils, in the pathogenesis of SJS/TEN. Here, we examined the expression of MPO in skin biopsy specimens from patients with SJS/TEN (n = 15) to evaluate its diagnostic utility, comparing the findings with those from patients with erythema multiforme (EM) (n = 8) and graft-versus-host disease (GVHD) (n = 10). MPO-positive mononuclear cells were present in all SJS/TEN cases, often outnumbering CD3-positive T cells (86.7%). A significantly higher number of cases with an MPO/CD3 ratio greater than 1 was observed in patients with SJS/TEN compared with that in patients with GVHD (p < 0.01). However, no such difference was observed between SJS/TEN and EM. These findings suggest that an MPO/CD3 > 1 is a pathologic feature of SJS/TEN; however, its specificity may be limited.</p>\",\"PeriodicalId\":23514,\"journal\":{\"name\":\"Virchows Archiv\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Virchows Archiv\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00428-025-04279-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virchows Archiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00428-025-04279-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
Myeloperoxidase-positive mononuclear cells predominate over CD3-positive T-lymphocytes in the epidermis of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening mucocutaneous conditions traditionally regarded as severe T cell-mediated hypersensitivity reactions. However, recent evidence has highlighted the potential role of myeloperoxidase (MPO), primarily produced by neutrophils, in the pathogenesis of SJS/TEN. Here, we examined the expression of MPO in skin biopsy specimens from patients with SJS/TEN (n = 15) to evaluate its diagnostic utility, comparing the findings with those from patients with erythema multiforme (EM) (n = 8) and graft-versus-host disease (GVHD) (n = 10). MPO-positive mononuclear cells were present in all SJS/TEN cases, often outnumbering CD3-positive T cells (86.7%). A significantly higher number of cases with an MPO/CD3 ratio greater than 1 was observed in patients with SJS/TEN compared with that in patients with GVHD (p < 0.01). However, no such difference was observed between SJS/TEN and EM. These findings suggest that an MPO/CD3 > 1 is a pathologic feature of SJS/TEN; however, its specificity may be limited.
期刊介绍:
Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.